Results

1–10 of 17 results for Central Serous Chorioretinopathy

2026 First-Place Poster Winner: Evaluating Sleep Disruption as a Modifiable Risk Factor for Central Serous Chorioretinopathy in a National Cohort of Over 5000 Patients
Updates from the Field
2026
Medical Case Conference: Kareem Moussa, MD
Kareem Moussa, MD
Annual Meeting Talks
2024
Central Serous Chorioretinopathy in Pregnancy (OS)
Vishal Agrawal, MD, FRCS,FACS,FASRS
Retina Image Bank: Images of the Week
2024
One-Year Outcome and Predictors of Treatment Outcome in Central Serous Chorioretinopathy: Multimodal Imaging Based Analysis
SUPRIYA ARORA, MS
Annual Meeting Talks
2021
Obstructive Sleep Apnea and Its Treatment Alter Choroidal Thickness in Patients With Central Serous Chorioretinopathy
Carolyn K Pan, MD
Annual Meeting Talks
2020
Effects of Ketoconazole on Clinical Recovery, Choroidal Thickness and Hormonal Profile in Patients With Central Serous Chorioretinopathy
Yodpong Chantarasorn, MD
Annual Meeting Talks
2020
Wet AMD 6 Symposium
Annual Meeting Talks
2020
Imaging, Digital, Angiography Symposium 2
Annual Meeting Talks
2020
Short-term Oral Mifepristone for the Treatment of Central Serous Chorioretinopathy (STOMP-CSC): A Placebo-Controlled Clinical Trial
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2018
Episode 158: Journal Club with Dr. Ajay Kuriyan and Dr. Shriji Patel, IVR versus IVA for wet AMD, Protocol T subanalysis, CSR natural history
Jayanth Sridhar, MD
Member Podcasts
2018